Galderma Group AG (GALDY)
38.91
+0.15
(+0.39%)
USD |
OTCM |
Oct 05, 16:00
Galderma Group Price : 38.91 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 39.05 | 39.10 | 38.82 | 38.91 | 103419.0 |
| Oct 02, 2026 | 38.19 | 39.37 | 38.19 | 38.76 | 84963.00 |
| Oct 01, 2026 | 39.37 | 39.37 | 38.52 | 38.80 | 111235.0 |
| Sep 30, 2026 | 40.35 | 40.35 | 39.45 | 39.59 | 75973.00 |
| Sep 29, 2026 | 39.69 | 39.87 | 39.53 | 39.87 | 139183.0 |
| Sep 28, 2026 | 38.77 | 39.22 | 38.77 | 39.10 | 357924.0 |
| Sep 25, 2026 | 39.59 | 40.10 | 39.26 | 39.45 | 135670.0 |
| Sep 24, 2026 | 38.75 | 39.48 | 38.75 | 39.33 | 347050.0 |
| Sep 23, 2026 | 39.65 | 39.78 | 38.83 | 38.85 | 935404.0 |
| Sep 22, 2026 | 40.79 | 40.79 | 39.58 | 39.83 | 893251.0 |
| Sep 21, 2026 | 39.12 | 39.51 | 39.01 | 39.14 | 410728.0 |
| Sep 18, 2026 | 38.79 | 38.79 | 38.31 | 38.49 | 150709.0 |
| Sep 17, 2026 | 38.38 | 38.57 | 38.10 | 38.14 | 200871.0 |
| Sep 16, 2026 | 36.93 | 37.56 | 36.73 | 37.11 | 121863.0 |
| Sep 15, 2026 | 37.65 | 37.65 | 37.09 | 37.18 | 926930.0 |
| Sep 14, 2026 | 38.11 | 38.21 | 37.85 | 38.01 | 148594.0 |
| Sep 11, 2026 | 38.42 | 38.61 | 37.76 | 37.76 | 165552.0 |
| Sep 10, 2026 | 37.92 | 38.26 | 37.63 | 37.66 | 296076.0 |
| Sep 09, 2026 | 39.60 | 39.60 | 38.18 | 38.27 | 475045.0 |
| Sep 08, 2026 | 40.44 | 40.62 | 39.81 | 39.81 | 333917.0 |
| Sep 04, 2026 | 39.95 | 40.05 | 38.89 | 39.03 | 491830.0 |
| Sep 03, 2026 | 40.72 | 40.97 | 39.73 | 40.31 | 150472.0 |
| Sep 02, 2026 | 40.48 | 40.85 | 40.36 | 40.74 | 78635.00 |
| Sep 01, 2026 | 41.16 | 41.28 | 40.74 | 40.87 | 64812.00 |
| Aug 31, 2026 | 41.67 | 41.76 | 41.25 | 41.39 | 99566.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sandoz Group AG | 84.55 |
| Novartis AG | 140.76 |
| Roche Holding AG | 52.51 |
| Addex Therapeutics Ltd. | 3.18 |
| Oculis Holding AG | 8.72 |
Price Related Metrics
| PE Ratio | 53.11 |
| PS Ratio | 7.778 |
| Price to Free Cash Flow | 43.43 |
| Earnings Yield | 1.88% |
| Market Cap | 45.37B |
| Operating PE Ratio | 41.97 |
| Normalized PE Ratio | 49.57 |